This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Newman Ferrara LLP Announces Investigation Of Physicians Formula Holdings Inc.

Newman Ferrara LLP has begun an investigation into potential claims against the board of directors of Physicians Formula Holdings Inc. (“Physicians Formula”) (NasdaqGS: FACE) concerning the merger agreement between Physicians Formula and private equity firm Swander Pace Capital.

On August 15, 2012, Physicians Formula announced that it had entered into a merger agreement to be acquired by Swander Pace Capital. Under the merger agreement, Physicians Formula shareholders will receive $4.25 in cash per share of Physicians Formula common stock owned . However, this offer price represents a premium of only 15% over the stock’s closing price on August 14, 2012. Physicians Formula stock traded above the offer price at $4.38 per share as recently as May 17, 2012 and Physicians Formula stock has increased approximately 15% so far this year. Physicians Formula’s announcement of the merger agreement comes just one day after Physicians Formula announced its financial results for the second quarter of 2012 during which Physicians Formula reported a 25% increase in net sales and announced that it had become “the fastest-growing masstige color cosmetics brand in dollar sales among the major five masstige brands.”

Physicians Formula’s Board of Directors has unanimously approved the merger agreement. Subject to approval by Physicians Formula’s shareholders, the proposed transaction is expected to close by the end of the calendar year.

Newman Ferrara LLP’s investigation concerns whether Physicians Formula’s Board of Directors is fulfilling its fiduciary duties to act in the best interests of Physicians Formula’s shareholders and to take all necessary steps to ensure that Physicians Formula’s shareholders receive the maximum value readily available for their shares of Physicians Formula stock.

Concerned investors are encouraged to contact Newman Ferrara attorney Roy Shimon at (212) 619-5400 or rshimon@nfllp.com to discuss this investigation, their rights, or potential remedies.

Newman Ferrara maintains a multifaceted practice based in New York City with attorneys specializing in complex commercial and multi-party litigation, securities fraud and shareholder litigation, consumer protection, civil rights, and real estate. For more information, please visit the firm website at www.nfllp.com.



1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,017.72 -52.68 -0.29%
S&P 500 2,106.51 -7.98 -0.38%
NASDAQ 4,970.2850 -46.6440 -0.93%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs